dimethyl phthalate has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Codd, R; Duncan, C; Liddell, JR; Telfer, TJ; White, AR | 1 |
1 other study(ies) available for dimethyl phthalate and Parkinson Disease
| Article | Year |
|---|---|
Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease.
Topics: Astrocytes; Cell Line; Cell Survival; Cells, Cultured; Deferoxamine; Humans; Iron; Iron Chelating Agents; Parkinson Disease; Polycyclic Compounds | 2017 |